Christopher J. Senner
CIK 1648367 · EVP and CFO · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$52.60M
Companies
3
Total Filings
65
Lifetime Open-Market Net
-$24.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-17 | EXEL | Tax (F) | −8,074 | -$173.7K | EDGAR |
| 2023-08-07 | EXEL | Mixed | — | -$702.6K | EDGAR |
| 2023-05-26 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | EXEL | Tax (F) | −18,446 | -$353.8K | EDGAR |
| 2023-04-05 | EXEL | Grant (A) | +85,414 | $0 | EDGAR |
| 2023-02-17 | EXEL | Tax (F) | −5,278 | -$95.4K | EDGAR |
| 2022-11-17 | EXEL | Tax (F) | −8,074 | -$134.9K | EDGAR |
| 2022-08-12 | EXEL | Mixed | +72,133 | -$1.54M | EDGAR |
| 2022-08-05 | EXEL | Mixed | +24,493 | -$173.5K | EDGAR |
| 2022-06-09 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.